Search Results

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

• Source: A Phase 2, Randomized, Open-label, Multicenter Study to Evaluate Efficacy, Pharmacokinetics, Safety, and Tolerability of Treatment With JNJ-73763989, Pegylated

Record details

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

• Authors : Alnylam Pharmaceuticals

• Source: A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of VIR-2218 Alone or in Combination With Pegylated

Record details

A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection (PENGUIN)

• Source: A Phase 2, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and

Record details

Efficacy of Pegylated Interferon Alpha-2a in Uveitic Macular Edema Refractory to Biologic Agents

• Authors : Mohammad Avarand; Mine Esen Baris; Leila Taheri

Subjects: Macular edema; Impact; uveitis

• Source: Ocular Immunology and Inflammation. 31:1900-1905

Record details

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection (PENGUIN-2)

• Source: A Phase 2, Open-label, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, Nucleos(t)Ide Analogs, and

Record details

Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon.

• Authors : De Simone, L.¹ (AUTHOR); Gentile, P.² (AUTHOR); Aldigeri, R.³ (AUTHOR)

• Source: Ocular Immunology & Inflammation. Jul2024, Vol. 32 Issue 5, p678-682. 5p.

Record details

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection.

• Authors : GOSMANN, Janika¹; STADLER, Rudolf¹ ; QUINT, Koen D.²

• Source: Acta Dermato-Venereologica. 2023, Vol. 103, p1-5. 5p.

Record details

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B

• Authors : Yi He; Yingzhi Zhou; Huimin Wang

Subjects: Chronic hepatitis B; Paediatrics; Entecavir

• Source: BMC Pediatrics, Vol 22, Iss 1, Pp 1-11 (2022)

Record details

Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B

• Authors : Ai Nakagawa-Iwashita; Akihito Tsubota; Atsushi Hiraoka

• Source: Internal Medicine. 2021, 60(4):507

Record details

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.

• Authors : Gill, Harinder¹ (AUTHOR); Leung, Garret M.K.¹ (AUTHOR); Yim, Rita¹ (AUTHOR)

• Source: Hematology. Dec2020, Vol. 25 Issue 1, p247-257. 11p.

Record details